Baton Rouge Area Foundation

Baton Rouge Area Foundation company information, Employees & Contact Information

Created in 1964, the Baton Rouge Area Foundation is among the largest community foundations in the country. We are working to build a thriving and resilient future for all in Baton Rouge and beyond. Our team delivers on this vision through the following key activities: Catalyzing change and positive opportunity in our community. The Foundation leads civic projects with annual support from our members. This work seeks to address the most pressing barriers to opportunity and is guided by data and community need. Fostering a strong philanthropic environment. We believe philanthropy is for everyone. The Foundation supports philanthropists at every stage of their journey of giving - providing education, counsel, and tools to help them support nonprofits and the community at large with their time, knowledge, and resources. Empowering changemakers and nonprofits. The Center for Nonprofit Excellence provides strategic and technical support to nonprofit organizations. We build relationships with and between nonprofits in our area, connect organizations to funding opportunities, offer consulting services for fundraising and planning, and lead educational fellowships.

Company Details

Employees
48
Founded
-
Address
100 North Street, Baton Rouge,louisiana 70802,united States
Industry
Non-Profit Organization Management
HQ
Baton Rouge, Louisiana
Looking for a particular Baton Rouge Area Foundation employee's phone or email?

Baton Rouge Area Foundation Questions

News

BRAF oncogenic mutants evade autoinhibition through a common mechanism - Science | AAAS

BRAF oncogenic mutants evade autoinhibition through a common mechanism Science | AAAS

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial - Nature

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial Nature

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations - The New England Journal of Medicine

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations The New England Journal of Medicine

BRAF and Lung Cancer - American Lung Association

BRAF and Lung Cancer American Lung Association

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective - Frontiers

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective Frontiers

Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition - EMBO Press

Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition EMBO Press

BRAF inhibition protects against hearing loss in mice - Science | AAAS

BRAF inhibition protects against hearing loss in mice Science | AAAS

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial | Nature Medicine - Nature

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial | Nature Medicine Nature

BRAF Alteration in Central and Peripheral Nervous System Tumors - Frontiers

BRAF Alteration in Central and Peripheral Nervous System Tumors Frontiers

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations - The New England Journal of Medicine

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations The New England Journal of Medicine

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer - The New England Journal of Medicine

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer The New England Journal of Medicine

Current State of Target Treatment in BRAF Mutated Melanoma - Frontiers

Current State of Target Treatment in BRAF Mutated Melanoma Frontiers

Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer - Frontiers

Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer Frontiers

Nivolumab in Previously Untreated Melanoma without BRAF Mutation - The New England Journal of Medicine

Nivolumab in Previously Untreated Melanoma without BRAF Mutation The New England Journal of Medicine

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas - Frontiers

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas Frontiers

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma - The New England Journal of Medicine

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma The New England Journal of Medicine

Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies - Frontiers

Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies Frontiers

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations - The New England Journal of Medicine

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations The New England Journal of Medicine

Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis - Frontiers

Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis Frontiers

Cutaneous adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis - Frontiers

Cutaneous adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis Frontiers

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer - Frontiers

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer Frontiers

Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report - Frontiers

Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report Frontiers

Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation | The EMBO Journal - EMBO Press

Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation | The EMBO Journal EMBO Press

BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS - Science | AAAS

BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS Science | AAAS

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma - The New England Journal of Medicine

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma The New England Journal of Medicine

Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma - The New England Journal of Medicine

Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma The New England Journal of Medicine

Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process - Frontiers

Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process Frontiers

BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export - PNAS

BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export PNAS

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma - The New England Journal of Medicine

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma The New England Journal of Medicine

RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors - The New England Journal of Medicine

RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors The New England Journal of Medicine

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation - The New England Journal of Medicine

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation The New England Journal of Medicine

BRAF Mutations in Hairy-Cell Leukemia - The New England Journal of Medicine

BRAF Mutations in Hairy-Cell Leukemia The New England Journal of Medicine

How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications - Wiley Online Library

How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications Wiley Online Library

Top Baton Rouge Area Foundation Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant